Scilex Holding Co Share Price Today
(NASDAQ: SCLX)

Name: Scilex Holding Co Share Price Today (NASDAQ: SCLX) - Scilex Holding Co Stock Price Live Quote | INDmoney
Brand: INDmoney
Rating: 4.7 (371551 reviews)

Scilex Holding Co share price is $0.4 & ₹34.84 as on 5 Feb 2025, 2.30 'hrs' IST

$0.4

▲

-0.02

(-5.29%)

Market is closed - opens 8 PM, 05 Feb 2025

View live Scilex Holding Co share price in Dollar and Rupees. Guide to invest in Scilex Holding Co stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Scilex Holding Co, along with analyst recommendations, forecasts, and comprehensive financials.

Scilex Holding Co share price movements

Today's Low: $0.38
Today's High: $0.42
$0.40
4.6%
Downside
Day's Volatility :8.84%
Upside
4.44%
52 Weeks Low: $0.37
52 Weeks High: $2.63
$0.40
7.5%
Downside
52 Weeks Volatility :85.93%
Upside
84.79%

Scilex Holding Co (SCLX) Returns

Period	Scilex Holding Co	Index (Russel 2000)
3 Months	-60.45%	0.0%
6 Months	-67.94%	0.0%
1 Year	-74.96%	0.0%
3 Years	-95.47%	-11.7%

Scilex Holding Co (SCLX) Key Statistics

in dollars & INR

Previous Close	$0.4232
Open	$0.404
Today's High	$0.4186
Today's Low	$0.3816
Market Capitalization	$75.5M
Today's Volume	$1.3M
52 Week High	$2.63
52 Week Low	$0.37
Revenue TTM	$50.8M
EBITDA	$-95.0M
Earnings Per Share (EPS)	$-0.81
Profit Margin	-233.88%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	0.0%

How to invest in Scilex Holding Co Stock (SCLX) from India?

It is very easy for Indian residents to invest directly in Scilex Holding Co from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Scilex Holding Co stock in both Indian Rupees (INR) and US Dollars (USD). Search for Scilex Holding Co or SCLX on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Scilex Holding Co or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Scilex Holding Co shares which would translate to 2.177 fractional shares of Scilex Holding Co as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Scilex Holding Co, in just a few clicks!

Returns in Scilex Holding Co (SCLX) for Indian investors in Rupees

The Scilex Holding Co stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

Scilex Holding Co investment value today

Current value as on today

₹28,533

Returns

₹71,467

(-71.47%)

Returns from Scilex Holding Co Stock

₹76,331 (-76.33%)

Dollar Returns

₹4,865 (+4.86%)

Indian investors sentiment towards Scilex Holding Co (SCLX)

-5%

Period: Jan 5, 2025 to Feb 4, 2025. Change in 30 Days versus previous period

Search interest for Scilex Holding Co Stock from India on INDmoney has decreased by -5% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Scilex Holding Co

State Street Corp
4.08%
BlackRock Inc
3.66%
Vanguard Group Inc
3.30%
Armistice Capital, LLC
1.92%
Millennium Management LLC
0.80%
Geode Capital Management, LLC
0.71%

Analyst Recommendation on Scilex Holding Co

Buy

87%Buy

12%Hold

0%Sell

Based on 8 Wall street analysts offering stock ratings for Scilex Holding Co(by analysts ranked 0 to 5 stars)

Based on 8 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Scilex Holding Co Stock (SCLX)

What analysts predicted

Upside of 2562.5%

Target:

$10.65

Current:

$0.40

Insights on Scilex Holding Co Stock (Ticker Symbol: SCLX)

Price Movement
In the last 3 months, SCLX stock has moved down by -56.1%
Decreasing Revenue
Revenue is down for the last 3 quarters, 16.37M → 14.43M (in $), with an average decrease of 5.9% per quarter
Increasing Net Profit
Netprofit is up for the last 3 quarters, -37.58M → -4.38M (in $), with an average increase of 378.2% per quarter
SCLX vs LLY (1 yr)
In the last 1 year, Eli Lilly And Company has given 21.4% return, outperforming this stock by 95.0%
Price to Sales
ForSCLX every $1 of sales, investors are willing to pay $1.0, whereas for Eli Lilly And Company, the investors are paying $17.9 for every $1 of sales.

Scilex Holding Co Technicals Summary

Sell

Neutral

Buy

Scilex Holding Co is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Scilex Holding Co (SCLX) Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Scilex Holding Co	-17.02%	-67.94%	-74.96%	-95.47%	-95.47%
Eli Lilly And Company	5.92%	4.96%	14.95%	232.76%	453.53%
Johnson & Johnson	5.71%	-4.42%	-3.92%	-11.22%	-0.01%
Merck & Co. Inc.	0.07%	-11.29%	-21.35%	28.63%	17.29%
Novo Nordisk A/s	-2.8%	-30.68%	-29.73%	62.44%	161.34%
Abbvie Inc	5.57%	1.4%	9.72%	33.4%	106.02%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Scilex Holding Co	NA	NA	NA	-0.54	0.0	-0.54	NA	-1.73
Eli Lilly And Company	87.61	87.61	0.77	12.88	0.65	0.14	0.01	15.83
Johnson & Johnson	26.23	26.23	0.96	10.55	0.21	0.08	0.03	29.14
Merck & Co. Inc.	20.67	20.67	0.07	7.62	0.28	0.11	0.03	17.58
Novo Nordisk A/s	28.53	28.53	1.41	22.15	0.89	0.21	0.02	27.07
Abbvie Inc	76.95	76.95	0.43	12.22	0.56	0.08	0.04	3.41

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Scilex Holding Co	Buy	$75.5M	-95.47%	NA	-233.88%
Eli Lilly And Company	Buy	$728.8B	453.53%	87.61	20.48%
Johnson & Johnson	Buy	$366.3B	-0.01%	26.23	16.74%
Merck & Co. Inc.	Buy	$250.0B	17.29%	20.67	19.23%
Novo Nordisk A/s	Buy	$374.4B	161.34%	28.53	35.01%
Abbvie Inc	Buy	$325.0B	106.02%	76.95	9.22%

About Scilex Holding Co

Scilex Holding Company focuses on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. Its commercial products include ZTlido (lidocaine topical system) 1.8% (ZTlido), a prescription lidocaine topical product for the relief of neuropathic pain associated with postherpetic neuralgia (PHN), which is a form of post-shingles nerve pain; ELYXYB, a ready-to-use oral solution for the acute treatment of migraine with or without aura in adults; and GLOPERBA, a liquid oral version of the anti-gout medicine colchicine indicated for the prophylaxis of painful gout flares in adults. The company is also developing three product candidates, including SP-102 (10 mg dexamethasone sodium phosphate viscous gel) (SEMDEXA), a novel viscous gel formulation of a used corticosteroid for epidural injections, which has completed a Phase 3 study to treat lumbosacral radicular pain or sciatica; SP-103 (lidocaine topical system) 5.4% (SP-103), a formulation of ZTlido for the treatment of chronic neck pain and low back pain (LBP) that has completed a Phase 2 trial; and SP-104 (4.5 mg low-dose naltrexone hydrochloride delayed-release capsules) (SP-104), a novel low-dose delayed-release naltrexone hydrochloride, which has completed Phase 1 trials for the treatment of fibromyalgia. The company has a collaboration with ACEA Therapeutics to Support the Expansion of ZTlido program. Scilex Holding Company is headquartered in Palo Alto, California.

Organization	Scilex Holding Co
Employees	113
CEO	Dr. Henry H. Ji Ph.D.
Industry	Healthcare

Management People of Scilex Holding Co

Name	Title
Dr. Henry H. Ji Ph.D.	Executive Chairman
Mr. Jaisim Shah	President, CEO & Director
Mr. Stephen Ma	Senior VP, CFO & Corporate Secretary
Dr. Suketu D. Desai Ph.D.	CTO & Senior VP
Mr. Steven F. Lincoln J.D.	General Counsel & Chief Compliance Officer
Mr. Sumant Rajendran	Executive Director of Marketing
Mr. Mike Ciaffi	National Sales Director
Mr. Suresh K. Khemani	Senior VP & Chief Commercial Officer
Dr. Dmitri V. Lissin M.D.	Senior VP & Chief Medical Officer
Ms. Gigi DeGuzman	Senior Executive Director & Chief of Staff

Important FAQs about investing in SCLX Stock from India :

What is Scilex Holding Co share price today?

Scilex Holding Co share price today stands at $0.40, Open: $0.40 ; Previous Close: $0.42 ; High: $0.42 ; Low: $0.38 ; 52 Week High: $2.63 ; 52 Week Low: $0.37.

The stock opens at $0.40, after a previous close of $0.42. The stock reached a daily high of $0.42 and a low of $0.38, with a 52-week high of $2.63 and a 52-week low of $0.37.

Can Indians buy Scilex Holding Co shares?

Yes, Indians can invest in the Scilex Holding Co (SCLX) from India.

With INDmoney, you can buy Scilex Holding Co at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Scilex Holding Co at zero transaction cost.

How can I buy Scilex Holding Co shares from India?

It is very easy to buy Scilex Holding Co from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Scilex Holding Co (SCLX) be purchased?

Yes, you can buy fractional shares of Scilex Holding Co with INDmoney app.

What are the documents required to start investing in Scilex Holding Co stocks?

To start investing in Scilex Holding Co, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.